PTC
RYTM icon

Private Trust Company’s Rhythm Pharmaceuticals RYTM Stock Holding History

Private Trust Company’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48
Closed -$2.52K – 2401
2024
Q3 		$2.52K Hold
48
– – ﹤0.01% 2127
2024
Q2 		$1.97K Sell
48
-4
-8% -$160 ﹤0.01% 2153
2024
Q1 		$2.25K Sell
52
-4
-7% -$175 ﹤0.01% 2098
2023
Q4 		$2.57K Sell
56
-26
-32% -$820 ﹤0.01% 2087
2023
Q3 		$1.88K Buy
+82
New +$1.84K ﹤0.01% 2129

Other funds holding RYTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Private Trust Company's RYTM Position: Q4 2024 in Review

Private Trust Company sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2024, closing a stake of 48 shares — an estimated $2.52K sold.

Private Trust Company first reported a position in RYTM in Q3 2023 and held it in 5 quarters. The position peaked at $2.57K in Q4 2023. 203 funds tracked by Wall St. Rank hold RYTM as of Q4 2024.

  • Private Trust Company reported no remaining Rhythm Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Private Trust Company sold 48 Rhythm Pharmaceuticals shares in Q4 2024, an estimated $2.52K.
  • Private Trust Company first reported a position in Rhythm Pharmaceuticals in Q3 2023 and held it in 5 quarters.
  • Private Trust Company's Rhythm Pharmaceuticals position peaked at $2.57K in Q4 2023.
  • 203 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2024.

Based on Private Trust Company's 13F filing for Q4 2024, filed 5 Feb 2025.